09:53 AM EST - ProMetic Life Sciences Inc. : Has entered into a strategic partnership with ProThera Biologics Inc. for the development and commercialization of human plasma-derived Inter-alpha Inhibitor Proteins. The agreements provide ProMetic with global, exclusive intellectual property rights to commercialize products for two clinical indications and both companies have strategic interest in the other's IAIP-related therapeutic areas through a royalty- bearing cross-license agreement. ProMetic Life Sciences Inc.
shares T.PLI are trading up $0.10 at $3.03.
